High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma
Open Access
- 10 April 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 33 (1), 32
- https://doi.org/10.1186/1756-9966-33-32
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapiesOncogene, 2013
- 5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 MutationsCancer Research, 2011
- Adiponectin receptor-1 expression is associated with good prognosis in gastric cancerJournal of Experimental & Clinical Cancer Research, 2011
- Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolomeProceedings of the National Academy of Sciences of the United States of America, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specificationNature, 2010
- Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNANucleic Acids Research, 2010
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1Science, 2009
- The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the BrainScience, 2009
- Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrenceHepatology, 2008